-
Dozens of civilians killed, kidnapped as jihadists clash in Nigeria
-
Ukraine strikes kill two children after Russia's deadly mall attack
-
Former envoys urge joint French, UK action on Palestinian territories
-
Pope visits San Marino, before addressing Italian political gathering
-
Australia lead by 101 in 2nd Bangladesh Test as 18 wickets fall on day one
-
Trump tariffs heap up as Canada tries to curb US reliance
-
'Aura' battles leap from social media to Latin America streets
-
Australia lose three wickets after skittling Bangladesh for 64
-
US, Canada fail to reach trade pact to avert Trump tariffs
-
Bangladesh all out for 64 in 2nd Test after Starc masterclass
-
Sudan farms lie barren as El Nino leaves Nile banks dry
-
Odyssey effect: stars sell Greece to a new wave of US tourists
-
Arctic shipping a daunting prospect in hotly contested region
-
South Korea to send first container ship through Arctic route
-
In US, rare earths extracted from coal mine wastewater
-
Starc takes 5-11 to leave Bangladesh reeling in 2nd Test
-
Nakashima pounds Fritz, Bejlek beats Keys in Cincinnati upsets
-
Injured Rune withdraws from US Open
-
Canadian negotiator says 'more work to do' on US trade deal
-
Nakashima knocks out Fritz to reach Cincinnati semi-finals
-
'Solid' Clark takes solo lead at BMW Championship
-
Ukraine says 'cynical' Russian strike on shopping centre killed 16
-
Arteta hails Arsenal's desire after perfect start to title defence
-
TikTok to pay $400 mn settlement in US children's privacy case
-
Betis down Real Sociedad in La Liga opener
-
MLS fines Messi for striking an opponent
-
Mexican governor resumes job despite US drug charges
-
Gouiri double fires Marseille past Strasbourg in Ligue 1 opener
-
Arsenal rout Coventry to open Premier League season in style
-
Mavericks buy out Thompson, now reportedly bound for Heat
-
Giant-killer Bejlek overhauls Keys to reach Cincinnati semi-finals
-
England v Pakistan first Test: Three talking points
-
Man Utd agree deal for Brighton midfielder Baleba: reports
-
US, Canada push to seal trade deal as deadline nears
-
Werro wins Lausanne 800m, well off world record pace
-
One dead, three wounded after sword attack at Swedish high school
-
China mulls bid to host 2028 UN climate talks: sources
-
Ukraine says 'cynical' Russian strike on shopping centre killed 15
-
Jones becomes third Englishman to join Inter this summer
-
US Supreme Court allows White House ballroom construction for now
-
Mexican governor wanted on US drug charges returns to job
-
Root hails emerging fast bowlers as England thrash Pakistan
-
Bolivia's Paz forced to fire economy minister in mid-crisis
-
Brazil's Lula urges tariffs resolution in call with Trump
-
A-Rod ups T-Wolves stake in $4.5bn ownership change
-
Ukraine says 'cynical' Russian strike on shopping centre killed 14
-
UK court orders Prince Harry, others to pay Daily Mail initial £9.5mn
-
Heatwave-hit Europe logs over 30,000 excess summer deaths: first figures
-
'Grateful' ex-world champion Alaphilippe retires from cycling
-
Give LIV Golf 'one more shot,' says DeChambeau
Medical Care Technologies (OTC PINK:MDCE) Begins Advanced Internal Beta Testing of MDCE Melanoma Scan Imaging Platform
Company initiates structured internal testing focused on platform stability, workflow optimization, and image consistency evaluation
MESA, AZ / ACCESS Newswire / June 12, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today announced the commencement of internal beta testing for its MDCE Melanoma Scan Beta platform.

The testing phase is designed to evaluate platform stability, workflow performance, image management functionality, interface responsiveness, and image consistency processes as the Company continues development of its AI-assisted imaging platform.
The MDCE Melanoma Scan Beta platform is being developed as an image organization and monitoring system intended to support longitudinal image management workflows. Internal testing will focus on identifying opportunities for refinement, validating core platform functions, and optimizing the overall user experience.
"Beginning structured internal testing represents an important milestone in our development process," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "Our focus is on building a stable, scalable, and well-engineered imaging platform through disciplined testing and continuous refinement."
The Company views the platform as part of its broader strategy involving AI-assisted imaging technologies, software infrastructure, and future digital wellness applications.
Medical Care Technologies emphasized that the MDCE Melanoma Scan Beta platform remains in beta-stage development. The pre-screening platform is not intended to treat, cure, or prevent any disease or medical condition and has not been reviewed or cleared by the U.S. Food and Drug Administration.
The Company expects to provide additional updates regarding testing milestones, platform enhancements, and future development initiatives as progress continues.
About Medical Care Technologies, Inc.
Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and consumer software innovation. The Company is actively developing technology initiatives involving AI-assisted imaging, computer vision, and scalable software platforms.
Contact Information
Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: [email protected]
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204
Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties. These statements include, but are not limited to, expectations regarding product development, testing activities, technology initiatives, future enhancements, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
A.Ruiz--AT